NCT04368897Withdrawn
In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Withdrawn
- Declared phase
- No phase declared
- Sponsor
- Applied Biology, Inc.
- Participants (registry)
- —
- Start
- May 2020 (planned)
- Primary completion
- December 2022
- Study completion
- December 2022
- Last registry update
- July 2023
- Countries
- Spain
Conditions studied: SARS-CoV 2, COVID, COVID-19, Androgenetic Alopecia, Androgen Receptor Abnormal, Androgen Deficiency
Interventions: CAG length <22, Genetic Test - Short CAG Allele, CAG length >=22, Genetic Test - Long CAG Allele
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.